Hepatitis C: Personalisierte Therapie

  • Optimale Dauer und Dosierung mit maximalen Ansprechraten bei limitierter Toxizität
  • Harald Hofer, Peter Ferenci
  • Wiener klinisches Magazin, October 2011, Springer Science + Business Media
  • DOI: 10.1007/s00740-011-0404-x

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s00740-011-0404-x

The following have contributed to this page: Peter Ferenci